Transforming growth factor-beta binds reversibly in vitro to Guglielmi detachable coils

被引:2
|
作者
Kallmes, DF
Hankins, GR
Borland, MK
Cloft, HJ
Jensen, ME
Dion, JE
Hell, GA
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Radiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Hlth Sci Ctr, Dept Neurol Surg, Charlottesville, VA 22908 USA
关键词
Guglielmi detachable coil; transforming growth factor; in vitro;
D O I
10.1177/159101999800400102
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We determined the propensity for and reversibility of transforming growth factor-beta (TGF beta) binding to uncoated Guglielmi Detachable Coils (GDC) and to GDC coated with extracellular matrix (ECM) proteins. Three 1.0 centimetre samples each of uncoated GDC-18 and of GDC-18 coated with either poly-L-lysine, laminin, type I collagen, type IV collagen, fibronectin, or poly-L-lysine and laminin were prepared. These samples were immersed briefly in a solution containing I-125-labelled TGF beta at a concentration of 0.225 mu g/ml with initial specific activity of 123.3 mCi/mg (DuPont-NEN, Billerica, MA), and were counted using a scintillation counter. Each sample was then placed in a vial containing saline shaken for 60 seconds, and counted again. Selected samples were immersed for varying periods within the TGF beta solution and counted before and after saline rinse. Samples were rinsed one week after initial rinsing and counted again. The amount of binding between coil types was compared using the Student t test. For all samples initial binding of TGF beta was in the order of 60-120 pg/cm. For the pre-rinse data there were no statistically significant differences between the amount bound to any single coil coating type relative to other coatings. Compared to the initial accumulations, the amount remaining after rinsing ranged from 40% (poly-L-lysine) to 63% (poly-L-lysine with laminin), with a mean of 55% among the seven coil types. After rinsing there was more growth factor remaining on uncoated coils than on poly-L-lysine-coated coils (p=0.05), fibronectin-coated coils (p=0.01), and type IV collagen-coated coils (p=0.04). There was a trend toward greater residual growth factor on coils coated with poly-L-lysine and laminin compared to coils coated with poly-L-lysine alone (p=0.10). Delayed second rinsing of the samples one week after initial testing demonstrated only minor incremental loss of TGF beta from the coil surfaces. After five minutes of immersion, accumulation was approximately 200% greater than that noted with brief submersion, but immersions lasting over five minutes did not yield increasing levels of TGF beta binding. TGF beta binds to GDC coils. Binding is not improved with ECM protein-coated coils compared to uncoated coils. The absolute amount of TGF beta bound to the coil will likely result in local concentrations of growth factor in the order of those required for biological activity in vivo.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Transforming growth factor-beta and its implication in the malignancy of gliomas
    Laurent-Olivier Roy
    Marie-Belle Poirier
    David Fortin
    Targeted Oncology, 2015, 10 : 1 - 14
  • [2] The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring
    Chalmers, Richard L.
    INTERNATIONAL WOUND JOURNAL, 2011, 8 (03) : 218 - 223
  • [3] The role of transforming growth factor-beta in identifying patients with coronary artery disease
    Stanojevic, N
    Jelic-Ivanovic, Z
    Durovic, S
    Spasojevic-Kalimanovska, V
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1999, 18 (2-3): : 85 - 89
  • [4] The nematode parasite Onchocerca volvulus generates the transforming growth factor-beta (TGF-beta)
    Korten, Simone
    Buettner, Dietrich W.
    Schmetz, Christel
    Hoerauf, Achim
    Mand, Sabine
    Brattig, Norbert
    PARASITOLOGY RESEARCH, 2009, 105 (03) : 731 - 741
  • [5] Cloning and sequencing of equine transforming growth factor-beta 1 (TGFβ-1) cDNA
    Penha-Goncalves, MN
    Onions, DE
    Nicolson, L
    DNA SEQUENCE, 1997, 7 (06): : 375 - 378
  • [6] Systemic transforming growth factor-beta in patients with bone marrow fibrosis -: Pathophysiological implications
    Rameshwar, P
    Chang, VT
    Thacker, UF
    Gascón, P
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 59 (02) : 133 - 142
  • [7] Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta
    Wong, Chun Yuen Jerry
    Baldelli, Alberto
    Gholizadeh, Hanieh
    Oguzlu, Hale
    Guo, Yigong
    Ong, Hui Xin
    Rodriguez, Athenea Pascal
    Singuera, Gurpreet
    Thamboo, Andrew
    Singh, Anika
    Pratap-Singh, Anubhav
    Traini, Daniela
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 189 : 202 - 211
  • [8] Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods
    Kim, HD
    Valentini, RF
    BIOMATERIALS, 1997, 18 (17) : 1175 - 1184
  • [9] Natural Products and Transforming Growth Factor-beta (TGF-β) Signaling in Cancer Development and Progression
    Lee, Chung
    Zhang, Qiang
    Kozlowski, James
    Brendler, Charles
    Soares, Marcelo B.
    Dash, Atrya
    McClelland, Michael
    McClelland, Michael
    Mercola, Dan
    CURRENT CANCER DRUG TARGETS, 2013, 13 (05) : 500 - 505
  • [10] Induction of transforming growth factor-beta 1 on dentine pulp cells in different culture patterns
    Nie, X
    Tian, WD
    Zhang, YJ
    Chen, XZ
    Dong, R
    Jiang, M
    Chen, FM
    Jin, Y
    CELL BIOLOGY INTERNATIONAL, 2006, 30 (04) : 295 - 300